Obinutuzumab for Follicular Lymphoma User Reviews
Brand names: Gazyva
- Buc...
- Taken for 2 to 5 years
- May 26, 2022
"I received obinutuzumab plus bendamustine for follicular lymphoma. After 6 months of treatment, the lymphoma went into remission. Then I continued on with obinutuzumab only for 2 years. I mostly struggled with fatigue, bloating, UTIs, and bladder pain, shortness of breath, and occasional headaches. The medication was administered through my port every 8 weeks once I was on maintenance."
- Pjm...
- Taken for less than 1 month
- January 30, 2025
"My oncologist switched me to obinutuzumab following a reaction to Rituxan after four courses of chemo RCHOP. So far, I have no issues after two fusions with three more to go. Very happy since obinutuzumab is apparently more effective."
Frequently asked questions
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Follicular Lymphoma
Care guides
More about obinutuzumab
- Check interactions
- Compare alternatives
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
"I was diagnosed with stage 4 follicular lymphoma in December 2021 and received 6 months of chemotherapy with obinutuzumab and bendamustine. All went well except for tiredness, especially towards the end of the 6-month cycle, and a lot of 'burping.' Scans showed that I am now in partial remission. I have since had two treatments of maintenance therapy and am starting to feel well again. I am very grateful to all the people who have developed such lifesaving therapy."